Open AccessPredictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
Author(s) -
Jinyu Zhu,
Bufu Tang,
Yang Gao,
Su-qin Xu,
Jianfei Tu,
Yajie Wang,
Wenting Yang,
Shiji Fang,
Qiaoyou Weng,
Zhao Zhi,
Min Xu,
Yang Yang,
Minjiang Chen,
Lu Chen,
Jiansong Ji
Publication year - 2021
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s315957
Subject(s) - cohort , oncology , medicine , proportional hazards model , hepatocellular carcinoma , framingham risk score , multivariate analysis , disease , immunotherapy , cancer
Hepatocellular carcinoma (HCC) is a heterogeneous molecular disease with complex molecular pathogenesis that influences the efficacy of therapies. Exosomes play a crucial role in tumorigenesis and poor disease outcomes in HCC.